Search for other papers by Yu Ah Hong in
Google Scholar
PubMed
Search for other papers by Kyung-Do Han in
Google Scholar
PubMed
Search for other papers by Jae-Seung Yun in
Google Scholar
PubMed
Search for other papers by Eun Sil Sil in
Google Scholar
PubMed
Search for other papers by Seung-Hyun Ko in
Google Scholar
PubMed
Search for other papers by Sungjin Chung in
Google Scholar
PubMed
.0 ± 2.6 154.1 ± 2.6 156.3 ± 2.7 160.8 ± 3.6 <0.001 Age (year) 58.5 ± 12.0 58.7 ± 12.2 57.2 ± 11.9 57.3 ± 11.7 57.7 ± 11.7 <0.001 Age (year, n (%)) <0.001 30–39 31,707 (6.2) 37,664 (7.0) 34,214 (6
Department of Endocrinology, Fujian Provincial Hospital, Fujian, China
Search for other papers by Yaqian Mao in
Google Scholar
PubMed
Search for other papers by Lizhen Xu in
Google Scholar
PubMed
Search for other papers by Ting Xue in
Google Scholar
PubMed
Search for other papers by Jixing Liang in
Google Scholar
PubMed
Search for other papers by Wei Lin in
Google Scholar
PubMed
Search for other papers by Junping Wen in
Google Scholar
PubMed
Search for other papers by Huibin Huang in
Google Scholar
PubMed
Search for other papers by Liantao Li in
Google Scholar
PubMed
Department of Endocrinology, Fujian Provincial Hospital, Fujian, China
Fujian Provincial Key Laboratory of Medical Analysis, Fujian Academy of Medical, Fujian, China
Search for other papers by Gang Chen in
Google Scholar
PubMed
model constructed by the aforementioned predictors was represented by a nomogram (see Fig. 3 for details). Figure 3 Nomogram prediction for the 3-year risk of osteoporosis. Predictors contained in the prediction nomogram included age, NC, WHtR
Search for other papers by Zhiyan Yu in
Google Scholar
PubMed
Search for other papers by Yueyue Wu in
Google Scholar
PubMed
Search for other papers by Rui Zhang in
Google Scholar
PubMed
Search for other papers by Yue Li in
Google Scholar
PubMed
Search for other papers by Shufei Zang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
diabetes (year) 10.00 (6.00, 20.00) 10.00 (6.00, 18.00) 0.155 10.00 (5.00, 15.00) 10.00 (4.00, 16.00) 0.847 13.00 (8.00, 20.00) 10.00 (7.00, 18.00) 0.054 ALT (U/L) 15.70 (11.00, 22.00) 21.00 (14.00, 29.80) <0.001 16.00 (11
Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Search for other papers by Nekoo Panahi in
Google Scholar
PubMed
Kiel Institute for the World Economy, Kiel, Germany
Search for other papers by Sahar Saeedi Moghaddam in
Google Scholar
PubMed
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science, Tehran, Iran
Search for other papers by Noushin Fahimfar in
Google Scholar
PubMed
Search for other papers by Negar Rezaei in
Google Scholar
PubMed
Search for other papers by Mahnaz Sanjari in
Google Scholar
PubMed
Search for other papers by Mohammad-Mahdi Rashidi in
Google Scholar
PubMed
Search for other papers by Parnian Shobeiri in
Google Scholar
PubMed
Search for other papers by Bagher Larijani in
Google Scholar
PubMed
Search for other papers by Afshin Ostovar in
Google Scholar
PubMed
low-impact trauma and each standard deviation decrease in femoral neck BMD is associated with a two- to three-fold increase in the risk of fracture ( 3 ) with the consequent morbidity and mortality and health expenditures ( 4 , 5 ). Osteoporosis is a
Search for other papers by Yongli Fu in
Google Scholar
PubMed
Search for other papers by Yaowu Sun in
Google Scholar
PubMed
Search for other papers by Jiankun Zhang in
Google Scholar
PubMed
Search for other papers by Yu Cheng in
Google Scholar
PubMed
.98 0.84–1.16 1.6 3 Mixed ICU 1.04 0.95–1.12 18.5 7 Trial year 0.074 Year 2001–2009 1.06 0.99–1.13 0 9 Year 2010–2017 1.02 0.97–1.08 0 5 Study region 0
TRIXY Center of Expertise, Leiden University Treatment and Expertise Centre (LUBEC), Sandifortdreef, Leiden, The Netherlands
Leiden Institute for Brain and Cognition, Leiden University, Wassenaarseweg, Leiden, The Netherlands
Search for other papers by Sophie van Rijn in
Google Scholar
PubMed
TRIXY Center of Expertise, Leiden University Treatment and Expertise Centre (LUBEC), Sandifortdreef, Leiden, The Netherlands
Leiden Institute for Brain and Cognition, Leiden University, Wassenaarseweg, Leiden, The Netherlands
Search for other papers by Kimberly Kuiper in
Google Scholar
PubMed
TRIXY Center of Expertise, Leiden University Treatment and Expertise Centre (LUBEC), Sandifortdreef, Leiden, The Netherlands
Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC, Sophia Children’s Hospital, Dr. Molewaterplein, Rotterdam, The Netherlands
Search for other papers by Nienke Bouw in
Google Scholar
PubMed
TRIXY Center of Expertise, Leiden University Treatment and Expertise Centre (LUBEC), Sandifortdreef, Leiden, The Netherlands
Department of Clinical, Neuro, and Developmental Psychology, Vrije Universiteit Amsterdam, Van der Boechorststraat, Amsterdam, The Netherlands
Search for other papers by Evelien Urbanus in
Google Scholar
PubMed
TRIXY Center of Expertise, Leiden University Treatment and Expertise Centre (LUBEC), Sandifortdreef, Leiden, The Netherlands
Leiden Institute for Brain and Cognition, Leiden University, Wassenaarseweg, Leiden, The Netherlands
Search for other papers by Hanna Swaab in
Google Scholar
PubMed
-emotional functioning. When comparing the SCT and the control group across the 1- to 5-year age range, higher incidences of social-emotional functioning problems, affective behavior problems, and pervasive developmental problems became apparent. Risk assessment showed
Search for other papers by Franca Genest in
Google Scholar
PubMed
Search for other papers by Michael Schneider in
Google Scholar
PubMed
Search for other papers by Andreas Zehnder in
Google Scholar
PubMed
Search for other papers by Dominik Lieberoth-Leden in
Google Scholar
PubMed
Search for other papers by Lothar Seefried in
Google Scholar
PubMed
test continuously increased from 8.54 s in the 65–69 year group to 12.34 s in the ≥85 year cohort ( P < 0.001). The average SPPB-score decreased progressively starting from 11.7 points for the 65–69 year group to 9.5 points in the ≥85 year old ( P < 0
Search for other papers by Yinqiong Huang in
Google Scholar
PubMed
Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
Search for other papers by Zhaozhao Zhu in
Google Scholar
PubMed
Search for other papers by Zhiqin Huang in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
.18 ± 2.83 25.31 ± 3.42 a 23.86 ± 3.99 9.651 0.000 d Diabetes duration (year) NA 5.0 (1.0, 10) 10 (4.25,16.0) b −2.752 0.006 d Hypertension (%) NA 32.9% (24/73) 51.4% (18/35) b 4.210 0.040 b BUN (mmol/L) 4
Search for other papers by Lu Liu in
Google Scholar
PubMed
Search for other papers by Chunyan Li in
Google Scholar
PubMed
Search for other papers by Peng Yang in
Google Scholar
PubMed
Search for other papers by Jian Zhu in
Google Scholar
PubMed
Search for other papers by Dongmei Gan in
Google Scholar
PubMed
Search for other papers by Le Bu in
Google Scholar
PubMed
Search for other papers by Manna Zhang in
Google Scholar
PubMed
Search for other papers by Chunjun Sheng in
Google Scholar
PubMed
Search for other papers by Hong Li in
Google Scholar
PubMed
Search for other papers by Shen Qu in
Google Scholar
PubMed
fractures in people with osteoporosis and those at a high risk of fractures (3, 4, 5) . Alendronate (ALN) is a potent oral bisphosphonate with a prolonged duration of action and is the most commonly prescribed bisphosphonate (6) . The pharmacokinetics of
Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed
Search for other papers by Iwona Pałyga in
Google Scholar
PubMed
Search for other papers by Monika Szymonek in
Google Scholar
PubMed
Search for other papers by Artur Kowalik in
Google Scholar
PubMed
Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed
Search for other papers by Anna Słuszniak in
Google Scholar
PubMed
Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed
Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed
Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
the number of new cases mostly affects low-stage papillary thyroid cancer (PTC), which responds well to treatment and has a low risk of recurrence ( 5 , 6 ). These epidemiological changes modified the approach to treatment and monitoring of DTC. In